Jennifer J Knox

Jennifer J Knox

UNVERIFIED PROFILE

Are you Jennifer J Knox?   Register this Author

Register author
Jennifer J Knox

Jennifer J Knox

Publications by authors named "Jennifer J Knox"

Are you Jennifer J Knox?   Register this Author

100Publications

3104Reads

35Profile Views

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.

Br J Cancer 2019 Jun 20;120(12):1113-1119. Epub 2019 May 20.

Department of Medical Oncology and Haematology Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0474-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738062PMC
June 2019

Locally advanced pancreatic cancer: An emerging entity.

Curr Probl Cancer 2018 Jan - Feb;42(1):12-25. Epub 2017 Nov 16.

Princess Margaret Cancer Centre, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2017.10.006DOI Listing
April 2019

Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

Cancer Cell 2019 02 24;35(2):267-282.e7. Epub 2019 Jan 24.

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Surgery, University of Toronto, Toronto, ON M5T 1P5, Canada; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, ON M5G 2M9, Canada; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183058
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398439PMC
February 2019

Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis.

Eur J Cancer 2018 12 29;105:1-9. Epub 2018 Oct 29.

Department of Medical Oncology, Princess Margaret Cancer Centre/University of Toronto, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183140
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.09.031DOI Listing
December 2018

Adjuvant Therapy for Biliary Tract Cancers.

J Oncol Pract 2018 12;14(12):701-708

South East Cancer Center, University Hospital Waterford, Waterford, Ireland; and Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00558
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00558DOI Listing
December 2018

Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).

Int J Radiat Oncol Biol Phys 2018 07 12;101(4):900-909. Epub 2018 Apr 12.

Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.04.011DOI Listing
July 2018

Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.

Clin Colorectal Cancer 2018 03 23;17(1):73-79. Epub 2017 Oct 23.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2017.10.010DOI Listing
March 2018

Phase I trial of radiation therapy and sorafenib in unresectable liver metastases.

Radiother Oncol 2017 05 13;123(2):234-239. Epub 2017 Feb 13.

Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.01.018DOI Listing
May 2017

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.

Cancer Med 2017 02 11;6(2):361-373. Epub 2017 Jan 11.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.989DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313634PMC
February 2017

Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status.

Eur J Cardiothorac Surg 2017 Jan 8;51(1):148-154. Epub 2016 Aug 8.

Division of Thoracic Surgery, University of Toronto, Toronto, ON, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezw264DOI Listing
January 2017

Adjuvant therapy for resected biliary tract cancer: a review.

Chin Clin Oncol 2016 Oct 5;5(5):64. Epub 2016 Sep 5.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.08.05DOI Listing
October 2016

FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience.

Br J Cancer 2016 09 28;115(6):649-54. Epub 2016 Jul 28.

Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/bjc2016222
Publisher Site
http://dx.doi.org/10.1038/bjc.2016.222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023770PMC
September 2016

Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers.

J Clin Pathol 2016 Aug 13;69(8):695-701. Epub 2016 Jan 13.

Department of Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jcp.bmj.com/content/early/2016/01/13/jclinpath-2015-2
Web Search
http://dx.doi.org/10.1136/jclinpath-2015-203397DOI Listing
August 2016

Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients with esophageal cancer.

J Thorac Cardiovasc Surg 2016 Jun 24;151(6):1571-80. Epub 2016 Feb 24.

Division of Thoracic Surgery, University of Toronto, Toronto, Ontario, Canada; Divison of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2016.01.052DOI Listing
June 2016

Changes in Liver Volume Observed Following Sorafenib and Liver Radiation Therapy.

Int J Radiat Oncol Biol Phys 2016 Mar 17;94(4):729-37. Epub 2015 Dec 17.

Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.12.015DOI Listing
March 2016

The comprehensive geriatric assessment in oncology: promises, pitfalls, and practicalities.

Hosp Pract (1995) 2010 ;38(3):128-36

Princess Margaret Hospital/University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3810/hp.2010.06.306
Publisher Site
http://dx.doi.org/10.3810/hp.2010.06.306DOI Listing
February 2016

Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.

Carcinogenesis 2015 Sep 25;36(9):956-62. Epub 2015 May 25.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgv073DOI Listing
September 2015

Outcome of adjuvant therapy in biliary tract cancers.

Am J Clin Oncol 2015 Aug;38(4):382-7

Departments of *Medical Oncology ∥Palliative Care Medicine #Radiation Oncology, Princess Margaret Hospital Departments of §Surgery ¶Pathology, Toronto General Hospital, Toronto, ON, Canada †Department of Gastroenterology, Edouard Herriot Hospital, Lyon, France ‡Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31829e19fbDOI Listing
August 2015

Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.

Clin Genitourin Cancer 2015 Aug 7;13(4):e229-e233. Epub 2015 Feb 7.

Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.02.001DOI Listing
August 2015

Localized and systemic approaches to treating hepatocellular carcinoma.

J Clin Oncol 2015 Jun 27;33(16):1835-44. Epub 2015 Apr 27.

All authors: University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1153DOI Listing
June 2015

A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma.

Cancer 2015 May 6;121(10):1620-7. Epub 2015 Jan 6.

Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; The Christie NHS Foundation Trust/University of Manchester, Withington, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29227DOI Listing
May 2015

Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis.

Eur Urol 2015 Apr 2;67(4):740-9. Epub 2014 Jun 2.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.05.010DOI Listing
April 2015

A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.

Invest New Drugs 2015 Feb 16;33(1):241-6. Epub 2014 Oct 16.

Staff Medical Oncologist, Gastrointestinal Oncology Lead, Princess Margaret Cancer Centre, University of Toronto, 5-210, 610 University Ave, Toronto, ON, M5G 2 M9, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10637-014-0169
Web Search
http://link.springer.com/10.1007/s10637-014-0169-3
Publisher Site
http://dx.doi.org/10.1007/s10637-014-0169-3DOI Listing
February 2015

Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: the ALBI scoring model.

Authors:
Jennifer J Knox

J Clin Oncol 2015 Feb 15;33(6):529-31. Epub 2014 Dec 15.

University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.0521DOI Listing
February 2015

Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer.

J Geriatr Oncol 2015 Jan 7;6(1):23-8. Epub 2014 Oct 7.

Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2014.09.183DOI Listing
January 2015

Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone.

Prostate 2014 Oct 11;74(14):1462-4. Epub 2014 Aug 11.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22861DOI Listing
October 2014

Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole.

Eur J Cancer 2014 Sep 16;50(14):2399-407. Epub 2014 Jul 16.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.06.004DOI Listing
September 2014

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.

J Clin Oncol 2014 Sep 21;32(25):2765-72. Epub 2014 Jul 21.

Robert J. Motzer, Memorial Sloan-Kettering Cancer Center, New York, NY; Carlos H. Barrios, PUCRS School of Medicine, Porto Alegre, Brazil; Tae Min Kim, Seoul National University Hospital; and Sun Young Rha, Severance Hospital, Yonsei Cancer Center, Seoul, Korea; Silvia Falcon, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru; Thomas Cosgriff, Hematology and Oncology Specialists, Metairie, LA; Graydon Harker, Utah Cancer Specialists, Salt Lake City, UT; Vichien Srimuninnimit, Siriraj Hospital, Mahidol, Thailand; Ken Pittman, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia; Roberto Sabbatini, Azienda Ospedaliero Universitaria Policlinico di Modena, Italy; Thomas W. Flaig, University of Colorado Cancer Center, Aurora, CO; Ray Page, Center for Cancer and Blood Disorders, Fort Worth, TX; Sevil E. Bavbek, American Hospital, Istanbul, Turkey; J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Poulam Patel, University of Nottingham, United Kingdom; Foon-yiu Cheung, Queen Elizabeth Hospital, Kowloon, Hong Kong; Sunil Yadav, Saskatoon Cancer Centre, Saskatoon, Saskatchewan; and Jennifer J. Knox, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada; Edward M. Schiff, Dalila Sellami, and Xufang Wang, Novartis Oncology, East Hanover, NJ; Julie Niolat, Novartis Pharma SAS, Rueil-Malmaison, France; and Oezlem Anak, Novartis Pharma AG, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.6911
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.6911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569681PMC
September 2014

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

J Natl Cancer Inst 2014 Jun 29;106(6):dju124. Epub 2014 May 29.

Affiliations of authors: Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (AJT, MGM, FEV-B, PA, RL-A, JJK, IFT, EA); Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia (BS); Medical Oncology University Hospital, Albacete, Spain (AO); University of Alabama, Birmingham Comprehensive Cancer Center, Birmingham, AL (GS); Department of Medical Oncology, Royal Melbourne Hospital, Melbourne, Australia (BT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju124DOI Listing
June 2014

Systemic therapy for hepatocellular carcinoma.

Hepat Oncol 2014 Jan 20;1(1):23-38. Epub 2013 Dec 20.

Department of Medical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/hep.13.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114012PMC
January 2014

State-of-the-art in the management of locally advanced and metastatic gallbladder cancer.

Curr Opin Oncol 2013 Jul;25(4):425-31

Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3283620fd8DOI Listing
July 2013

Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.

Oncologist 2012 7;17(12):1504-7. Epub 2012 Dec 7.

Massachusetts General Hospital, 55 Fruit Street, Cancer Center POB Room 232, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528382PMC
June 2013

Endoscopic or percutaneous biliary drainage for Klatskin tumors?

J Vasc Interv Radiol 2013 Jan 22;24(1):113-21. Epub 2012 Nov 22.

Division of Medical Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2012.09.019DOI Listing
January 2013

Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study.

Am J Clin Oncol 2012 Aug;35(4):322-8

Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318210f9ceDOI Listing
August 2012

Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.

J Gastrointest Cancer 2012 Jun;43(2):344-8

Medical Oncology, Princess Margaret Hospital, M5G 2C4, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12029-010-9194
Web Search
http://link.springer.com/10.1007/s12029-010-9194-4
Publisher Site
http://dx.doi.org/10.1007/s12029-010-9194-4DOI Listing
June 2012

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.

Cancer 2012 Jan 29;118(2):365-70. Epub 2011 Jun 29.

Department of Medical Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26201DOI Listing
January 2012

When your best is not good enough.

J Cancer Educ 2011 Sep;26(3):583-5

Department of Medical Oncology, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-010-0164-0DOI Listing
September 2011

Sunitinib rechallenge in metastatic renal cell carcinoma patients.

Cancer 2010 Dec 2;116(23):5400-6. Epub 2010 Nov 2.

Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25583
Publisher Site
http://dx.doi.org/10.1002/cncr.25583DOI Listing
December 2010

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

JAMA 2010 Nov;304(19):2154-60

Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2010.1672DOI Listing
November 2010

Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer.

Cancer 2010 Sep;116(17):4023-32

Department of Medical Oncology, Princess Margaret and Toronto General Hospitals of the University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25349
Publisher Site
http://dx.doi.org/10.1002/cncr.25349DOI Listing
September 2010

Renal cell carcinoma bone metastases: clinical advances.

Ther Adv Med Oncol 2010 Mar;2(2):75-83

Princess Margaret Hospital, Medical Oncology, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834009358417
Publisher Site
http://dx.doi.org/10.1177/1758834009358417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126010PMC
March 2010

Sunitinib in solid tumors.

Expert Opin Investig Drugs 2009 Jun;18(6):821-34

Princess Margaret Hospital, Division of Medical Oncology and Hematology, 610 University Avenue, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780902980171DOI Listing
June 2009

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

J Clin Oncol 2009 Apr 2;27(10):1585-91. Epub 2009 Mar 2.

Radiation Medicine Program, Department of Biostatistics and Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.0600DOI Listing
April 2009

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.

J Clin Endocrinol Metab 2009 Jan 11;94(1):5-9. Epub 2008 Nov 11.

Department of Medical Oncology, Princess Margaret Hospital, University Health Network, 610 University Avenue, M5G 2M9 Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2008-1836DOI Listing
January 2009

Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention.

J Thorac Cardiovasc Surg 2009 Jan;137(1):36-42

Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002252230801647
Publisher Site
http://dx.doi.org/10.1016/j.jtcvs.2008.09.049DOI Listing
January 2009